Patents by Inventor Vincent Miller

Vincent Miller has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11934469
    Abstract: In an embodiment, the disclosure provides computer-implemented systems and methods for providing graph-based recommendations of digital media collaborators for content creators. In an embodiment, the disclosure provides computers programmed to implement a networked, online platform for facilitating collaboration between content creators. In an example embodiment, the platform provides a system for recommending a collaborator for a particular content creator to create content with, of a specific content type. In another example embodiment, the platform provides a system for recommending a collaborator for a particular content creator to create content with, without restricting the content type, using a community detection algorithm. In embodiments, recommendations may be made partly based on centrality measures of creator nodes on a network graph programmatically calculated between content nodes of that network graph, or content nodes of a community detected in the network graph.
    Type: Grant
    Filed: August 6, 2021
    Date of Patent: March 19, 2024
    Assignee: PearPop Inc.
    Inventors: Joseph Miller, Vincent D. Tuscano, Cole A. Mason
  • Publication number: 20230372338
    Abstract: Methods and compositions for treating cholangiocarcinoma.
    Type: Application
    Filed: June 30, 2023
    Publication date: November 23, 2023
    Applicant: Foundation Medicine, Inc.
    Inventors: Siraj Mahamed ALI, Matthew J. HAWRYLUK, Jie HE, Doron LIPSON, Vincent A. MILLER, Jeffrey S. ROSS, Philip James STEPHENS
  • Patent number: 11771698
    Abstract: Methods and compositions for treating cholangiocarcinoma.
    Type: Grant
    Filed: March 17, 2021
    Date of Patent: October 3, 2023
    Assignee: Foundation Medicine, Inc.
    Inventors: Siraj Mahamed Ali, Matthew J. Hawryluk, Jie He, Doron Lipson, Vincent A. Miller, Jeffrey S. Ross, Philip James Stephens
  • Patent number: 11725247
    Abstract: Methods and compositions for treating cancer such as melanomas are disclosed.
    Type: Grant
    Filed: February 27, 2017
    Date of Patent: August 15, 2023
    Assignees: FOUNDATION MEDICINE, INC., VANDERBILT UNIVERSITY
    Inventors: Garrett Michael Frampton, Roman Yelensky, James Xin Sun, Douglas Buckner Johnson, Christine Marie Lovly, Jeffrey Alan Sosman, David Fabrizio, Philip James Stephens, Vincent A. Miller
  • Patent number: 11578372
    Abstract: Novel NTRK1 fusion molecules, detection reagents, and uses and kits for evaluating, identifying, assessing and/or treating a subject having a cancer are disclosed.
    Type: Grant
    Filed: November 14, 2019
    Date of Patent: February 14, 2023
    Assignee: Foundation Medicine, Inc.
    Inventors: Matthew J. Hawryluk, Doron Lipson, Vincent A. Miller, Philip James Stephens
  • Publication number: 20220399131
    Abstract: Provided are systems and methods for capturing outcome information associated with various cancer treatments. The system facilitates capture and analysis of cancer treatment information and associated outcome information. The treatment and outcome information can include genomic analysis and information on treatment of different cancers. The system can store and analyze any one or more of: tumor type, genomic alterations (e.g., genes and associated alterations, gene sequence mutations, alterations, amplifications, deletions, etc.), and treatment data (including, for example, treatments targeted to specific genes and/or genomic alterations). Users of the outcome system can supply and use the treatment and outcome information to facilitate diagnosis and therapy decisions. User interfaces within the system can be configured to allow users to easily locate outcome information associated with particular treatments of tumors having certain genomic alterations.
    Type: Application
    Filed: August 10, 2022
    Publication date: December 15, 2022
    Applicant: Foundation Medicine, Inc.
    Inventors: Michael PELLINI, Gary PALMER, Mary Patricia LANCELOTTA, Matthew J. HAWRYLUK, Vincent A. MILLER
  • Patent number: 11450438
    Abstract: A system for tracking and analyzing cancer treatment and outcome information includes a user interface (UI) component for allowing selection of an alteration, an affected gene, an affected pathway, a tumor type, and/or a treatment; a processor configured to receive treatment information and outcome information associated with a patient population; organize the treatment information and the outcome information into at least one tuple; and generate outcome summary information; and an analysis component configured to compare a current patient record for a current patient to existing treatment information for the patient population, identify similar patients in the patient population based on information in the current patient record, and filter a grouping of similar patients; the processor is further configured to display, on the UI component, the outcome summary information; enable navigation within the treatment and outcome information; and identify, based on the outcome information, an appropriate treatment f
    Type: Grant
    Filed: September 23, 2019
    Date of Patent: September 20, 2022
    Assignee: Foundation Medicine, Inc.
    Inventors: Michael Pellini, Gary Palmer, Mary Patricia Lancelotta, Matthew J. Hawryluk, Vincent A. Miller
  • Publication number: 20220251667
    Abstract: Novel mutant ESR1 molecules and uses are disclosed.
    Type: Application
    Filed: February 16, 2022
    Publication date: August 11, 2022
    Applicant: Foundation Medicine, Inc.
    Inventors: Maureen T. CRONIN, Garrett Michael FRAMPTON, Doron LIPSON, Vincent A. MILLER, Gary PALMER, Jeffrey S. ROSS, Philip James STEPHENS, Roman YELENSKY
  • Patent number: 11286532
    Abstract: Novel mutant ESR1 molecules and uses are disclosed.
    Type: Grant
    Filed: January 22, 2018
    Date of Patent: March 29, 2022
    Assignee: FOUNDATION MEDICINE, INC.
    Inventors: Maureen T. Cronin, Garrett Michael Frampton, Doron Lipson, Vincent A. Miller, Gary Palmer, Jeffrey S. Ross, Philip James Stephens, Roman Yelensky
  • Publication number: 20210283134
    Abstract: Methods and compositions for treating cholangiocarcinoma.
    Type: Application
    Filed: March 17, 2021
    Publication date: September 16, 2021
    Applicant: Foundation Medicine, Inc.
    Inventors: Siraj Mahamed ALI, Matthew J. HAWRYLUK, Jie HE, Doron LIPSON, Vincent A. MILLER, Jeffrey S. ROSS, Philip James STEPHENS
  • Patent number: 10980804
    Abstract: Methods and compositions for treating cholangiocarcinoma.
    Type: Grant
    Filed: January 17, 2014
    Date of Patent: April 20, 2021
    Assignee: FOUNDATION MEDICINE, INC.
    Inventors: Siraj Mahamed Ali, Matthew J. Hawryluk, Jie He, Doron Lipson, Vincent A. Miller, Jeffrey S. Ross, Philip James Stephens
  • Publication number: 20200299775
    Abstract: Novel NTRK1 fusion molecules, detection reagents, and uses and kits for evaluating, identifying, assessing and/or treating a subject having a cancer are disclosed.
    Type: Application
    Filed: November 14, 2019
    Publication date: September 24, 2020
    Inventors: Matthew J. Hawryluk, Doron Lipson, Vincent A. Miller, Philip James Stephens
  • Publication number: 20200211679
    Abstract: A system for tracking and analyzing cancer treatment and outcome information includes a user interface (UI) component for allowing selection of an alteration, an affected gene, an affected pathway, a tumor type, and/or a treatment; a processor configured to receive treatment information and outcome information associated with a patient population; organize the treatment information and the outcome information into at least one tuple; and generate outcome summary information; and an analysis component configured to compare a current patient record for a current patient to existing treatment information for the patient population, identify similar patients in the patient population based on information in the current patient record, and filter a grouping of similar patients; the processor is further configured to display, on the UI component, the outcome summary information; enable navigation within the treatment and outcome information; and identify, based on the outcome information, an appropriate treatment f
    Type: Application
    Filed: September 23, 2019
    Publication date: July 2, 2020
    Inventors: Michael Pellini, Gary Palmer, Mary Patricia Lancelotta, Matthew J. Hawryluk, Vincent A. Miller
  • Publication number: 20190233897
    Abstract: Novel mutant ESR1 molecules and uses are disclosed.
    Type: Application
    Filed: September 5, 2018
    Publication date: August 1, 2019
    Inventors: Maureen T. Cronin, Garrett Michael Frampton, Doron Lipson, Vincent A. Miller, Gary Palmer, Jeffrey S. Ross, Philip James Stephens, Roman Yelensky
  • Publication number: 20180320238
    Abstract: Novel mutant ESR1 molecules and uses are disclosed.
    Type: Application
    Filed: January 22, 2018
    Publication date: November 8, 2018
    Inventors: Maureen T. Cronin, Garrett Michael Frampton, Doron Lipson, Vincent A. Miller, Gary Palmer, Jeffrey S. Ross, Philip James Stephens, Roman Yelensky
  • Patent number: 10093983
    Abstract: Novel mutant ESR1 molecules and uses are disclosed.
    Type: Grant
    Filed: June 29, 2015
    Date of Patent: October 9, 2018
    Assignee: FOUNDATION MEDICINE, INC.
    Inventors: Maureen T. Cronin, Garrett Michael Frampton, Doron Lipson, Vincent A. Miller, Gary Palmer, Jeffrey S. Ross, Philip James Stephens, Roman Yelensky
  • Publication number: 20170016073
    Abstract: Novel mutant ESR1 molecules and uses are disclosed.
    Type: Application
    Filed: February 8, 2016
    Publication date: January 19, 2017
    Inventors: Maureen T. Cronin, Garrett Michael Frampton, Doron Lipson, Vincent A. Miller, Gary Palmer, Jeffrey S. Ross, Philip James Stephens, Roman Yelensky
  • Publication number: 20160201135
    Abstract: Novel mutant ESR1 molecules and uses are disclosed.
    Type: Application
    Filed: August 6, 2015
    Publication date: July 14, 2016
    Inventors: Maureen T. Cronin, Garrett Michael Frampton, Doron Lipson, Vincent A. Miller, Gary Palmer, Jeffrey S. Ross, Philip James Stephens, Roman Yelensky, Lior Soussan-Gutman, Addie Dvir, Ido Wolf
  • Publication number: 20160145691
    Abstract: Novel mutant ESR1 molecules and uses are disclosed.
    Type: Application
    Filed: June 29, 2015
    Publication date: May 26, 2016
    Inventors: Maureen T. Cronin, Garrett Michael Frampton, Doron Lipson, Vincent A. Miller, Gary Palmer, Jeffrey S. Ross, Philip James Stephens, Roman Yelensky
  • Publication number: 20150366866
    Abstract: Methods and compositions for treating cholangiocarcinoma.
    Type: Application
    Filed: January 17, 2014
    Publication date: December 24, 2015
    Inventors: Siraj Mahamed Ali, Matthew J. Hawryluk, Jie He, Doron Lipson, Vincent A. Miller, Jeffrey S. Ross, Philip James Stephens